In gastric cancer, based on IGSF11, the polypeptide vaccine that is designed can effectively enhance the function of CTLs (cytotoxic T lymphocytes), which are identified for their favorable role in tumor inhibition and patients’ survival [32]. This evidence concerns the gene IGSF11 and gastric cancer.